Randomized open-label trial of two simplified, class-sparing regimens following a first suppressive three or four-drug regimen

Margaret A FISCHL; Ann C COLLIER; Roland BASSETT; A. Lisa MUKHERJEE; Judith E FEINBERG; Lisa M DEMETER; Pablo TEBAS; Marina GIULIANO; Marjorie DEHLINGER; Kevin GARREN; Barbara BRIZ

doi:10.1097/QAD.0b013e328011ddfa

Back

Randomized open-label trial of two simplified, class-sparing regimens following a first suppressive three or four-drug regimen

Journal article

Peer reviewed

Randomized open-label trial of two simplified, class-sparing regimens following a first suppressive three or four-drug regimen

Margaret A FISCHL, Ann C COLLIER, Roland BASSETT, A. Lisa MUKHERJEE, Judith E FEINBERG, Lisa M DEMETER, Pablo TEBAS, Marina GIULIANO, Marjorie DEHLINGER, Kevin GARREN, …

AIDS (London), Vol.21(3), pp.325-333

2007

DOI: https://doi.org/10.1097/QAD.0b013e328011ddfa

PMID: 17255739

Abstract

Antiviral agents

Immunopathology

Infectious diseases

Pharmacology. Drug treatments

Viral diseases

Viral diseases of the lymphoid tissue and the blood. Aids

Biological and medical sciences

Medical sciences

Human viral diseases

Immunodeficiencies. Immunoglobulinopathies

Immunodeficiencies

Antibiotics. Antiinfectious agents. Antiparasitic agents

Metrics

4 Record Views

21 Times Cited - Web of Science

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types: Industry collaboration; Domestic collaboration; International collaboration
Citation topics: 1 Clinical & Life Sciences; 1.66 HIV; 1.66.1372 Lipodystrophy
Web Of Science research areas: Immunology; Infectious Diseases; Virology
ESI research areas: Immunology

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

Source: InCites

Details

Title: Randomized open-label trial of two simplified, class-sparing regimens following a first suppressive three or four-drug regimen
Creators: Margaret A FISCHL - Department of Medicine, University of Miami School of Medicine, Florida, United States
Ann C COLLIER - Division of Infectious Diseases, University of Washington School of Medicine, Seattle, Washington, United States
Roland BASSETT - Center for Biostatistics in AIDS Research, Harvard School of Public Heath, Boston, Massachusetts, United States
A. Lisa MUKHERJEE - Center for Biostatistics in AIDS Research, Harvard School of Public Heath, Boston, Massachusetts, United States
Judith E FEINBERG - Division of Infectious Diseases, University of Cincinnati College of Medicine, Cincinnati, Ohio, United States
Lisa M DEMETER - Division of Infectious Diseases, University of Rochester School of Medicine and Dentistry, Rochester, New York, United States
Pablo TEBAS - Division of Infectious Diseases, University of Pennsylvania, Philadelphia, Pennsylvania, United States
Marina GIULIANO - Istituto Superiore di Sanitá, Rome, Italy
Marjorie DEHLINGER - Division of AIDS, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland, United States
Kevin GARREN - Abbott Laboratories, Abbott Park, Illinois, United States
Barbara BRIZ - Social and Scientific Systems, Inc, Silver Spring, Maryland, United States
Publication Details: AIDS (London), Vol.21(3), pp.325-333
Publisher: Lippincott Williams & Wilkins; Hagerstown, MD
Academic Unit: Miller School of Medicine; UMMG Dept of Medicine - Infectious Diseases
Language: English
Resource Type: Journal article
PMID: 17255739
Record Identifier: 991031576558102976